PRLD Competitors & Alternatives
Compare Prelude Therapeutics Inc with similar stocks in the same industry
Biotechnology
PRLD
Main Stock$3.52
Tradestie Score
40
Market Cap
$85.47M
Revenue Growth
0.4%
Analyst Upside
+161.4%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ANNX
Annexon, Inc. Common Stock
|
$3.97
|
$332.96M | - | 49 | Compare |
|
REPL
Replimune Group, Inc.
|
$21.98
|
$328.62M | - | 28 | Compare |
|
EPRX
Eupraxia Pharmaceuticals Inc. Common Stock
|
$7.81
|
$307.12M | - | 36 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$8.39
|
$304.12M | - | 51 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$15.87
|
$297.23M | - | 30 | Compare |
|
OMER
Omeros Corporation
|
$17.99
|
$281.75M | 14.9 | 52 | Compare |
|
FHTX
Foghorn Therapeutics Inc. Common Stock
|
$2.05
|
$278.69M | 23.2 | 31 | Compare |
|
DBVT
DBV Technologies S.A.
|
$11.43
|
$275.54M | - | 22 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$19.32
|
$269.08M | 0.1 | 47 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 51 | Compare |
More PRLD Analysis
Data updated: Nov 13, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry